Grand River Hospital is a 665-bed hospital serving Waterloo Region, Ontario, Canada, and surrounding communities, primarily through its KW and Freeport Sites, both located in Kitchener. The two sites were independent hospitals that merged to form Grand River Hospital in April 1995.

There are 665 beds in Grand River Hospital.

During the past decade, Grand River Hospital conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 5 clinical trials were completed, i.e. on average, 27.8% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 5 clinical trials were completed. i.e. 55.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Grand River Hospital" #1 sponsor was "McMaster University" with 5 trials, followed by "Hoffmann-La Roche" with 3 trials sponsored, "Grand River Hospital" with 2 trials sponsored, "Merck Sharp & Dohme LLC" with 2 trials sponsored and "Bristol-Myers Squibb" with 2 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Grand River Hospital" #1 collaborator was "Canadian Institutes of Health Research (CIHR)" with 4 trials as a collaborator, "Australian and New Zealand Intensive Care Society Clinical Trials Group" with 2 trials as a collaborator, "Canadian Critical Care Trials Group" with 2 trials as a collaborator, "Grand River Hospital" with 2 trials as a collaborator and "Hamilton Health Sciences Corporation" with 2 trials as a collaborator. Other collaborators include 27 different institutions and companies that were collaborators in the rest 36 trials.

According to Clinical.Site data, the most researched conditions in "Grand River Hospital" are "COVID-19" (2 trials), "Covid19" (2 trials), "Prostatic Neoplasms" (2 trials), "Anastomotic Leak" (1 trials) and "Antibiotic-associated Diarrhea" (1 trials). Many other conditions were trialed in "Grand River Hospital" in a lesser frequency.

Most popular intervention types in "Grand River Hospital" are "Drug" (16 trials), "Other" (5 trials), "Biological" (4 trials), "Device" (2 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Convalescent plasma" (2 trials), "Dexamethasone" (2 trials), "Docetaxel" (2 trials) and "Paclitaxel" (2 trials). Other intervention names were less common.

The vast majority of trials in "Grand River Hospital" are 19 trials for "All" genders, 4 trials for "Male" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Grand River Hospital". undefined are not yet recruiting, 5 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Grand River Hospital, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Grand River Hospital, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 3 trials that are defined as “Not Applicable".

Grand River Hospital has several departments that took part in Clinical trials: "Grand River Regional Cancer Centre" - 57 trials